Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Acclarent Execs Move To Appeal Off-Label Conviction

Executive Summary

Attorneys for former Acclarent executives William Facteau and Patrick Fabian have filed a request that their convictions on off-label marketing charges either be set aside or that they be granted a new trial, citing other recent off-label trials and misconduct by the government.

Advertisement

Related Content

Acclarent Whistleblower Says Device Off-Label Marketing Too Risky
Park Prosecutions Are Expected To Continue: Here Are Some Tips
Acclarent Pays $18m To Settle False-Claims Allegations
Former Acclarent Execs Convicted Of Misdemeanors In Off-Label Case
Vascular Solutions Case (Partially) Points Way Forward For Off-Label Marketing

Topics

Related Companies

Advertisement
UsernamePublicRestriction

Register

MT103806

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

All set! This Question has been sent to my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Add a personalized Question to your Analyst

Cancel